Information:
Fel:
ID
28063
Beskrivning
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00810680
Länk
https://clinicaltrials.gov/show/NCT00810680
Nyckelord
Versioner (1)
- 2017-12-13 2017-12-13 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
13 december 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Lymphocytic Leukemia NCT00810680
Eligibility Chronic Lymphocytic Leukemia NCT00810680
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT00810680
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Chronic Lymphocytic Leukemia
Item
active cll (as defined by the national cancer institute working group)
boolean
C0023434 (UMLS CUI [1])
Prior Therapy Quantity Chronic Lymphocytic Leukemia | Nucleoside Analogs
Item
patients must have received at least one prior therapy for cll and have been treated with a nucleoside analogue.
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1579410 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1579410 (UMLS CUI [2])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
General health good
Item
good general condition as defined by an eastern cooperative oncology group-
boolean
C1277245 (UMLS CUI [1])
ECOG performance status
Item
performance status (ecog-ps) </=2.
boolean
C1520224 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement | Exception Count Due to Disease
Item
absolute neutrophil count>1500/cmm and platelet count >30,000/cmm unless the low counts are due to the disease.
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0750480 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0012634 (UMLS CUI [3,4])
C0032181 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0750480 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0012634 (UMLS CUI [3,4])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Exception Abnormality Due to Disease
Item
adequate liver function (bilirubin<2 mg/dl,astoralt <3xthe upper limit of normal) and renal function (serum creatinine<2 mg/dl or creatinine clearance>30 ml/min) unless abnormalities are as a result of disease involvement.
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0232804 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C0373595 (UMLS CUI [7])
C1705847 (UMLS CUI [8,1])
C1704258 (UMLS CUI [8,2])
C0678226 (UMLS CUI [8,3])
C0012634 (UMLS CUI [8,4])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0232804 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C0373595 (UMLS CUI [7])
C1705847 (UMLS CUI [8,1])
C1704258 (UMLS CUI [8,2])
C0678226 (UMLS CUI [8,3])
C0012634 (UMLS CUI [8,4])
Prior Therapy Recovery
Item
full recovery from previous treatments.
boolean
C1514463 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,2])
Therapeutic procedure Recent CLL
Item
any therapy for cll within 4 weeks before initiating treatment on this study.
boolean
C0087111 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
Pregnancy
Item
pregnancy.
boolean
C0032961 (UMLS CUI [1])